Kenji Sugamura
About
In The Last Decade
Kenji Sugamura
16 papers receiving 349 citations
Peers
Comparison fields: 5 of 64
- Molecular Biology 217
- Oncology 147
- Cancer Research 85
- Immunology 60
- Pathology and Forensic Medicine 57
Countries citing papers authored by Kenji Sugamura
This map shows the geographic impact of Kenji Sugamura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenji Sugamura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenji Sugamura more than expected).
Fields of papers citing papers by Kenji Sugamura
This network shows the impact of papers produced by Kenji Sugamura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenji Sugamura. The network helps show where Kenji Sugamura may publish in the future.
Co-authorship network of co-authors of Kenji Sugamura
This figure shows the co-authorship network connecting the top 25 collaborators of Kenji Sugamura. A scholar is included among the top collaborators of Kenji Sugamura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenji Sugamura. Kenji Sugamura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 0 | |
| 3 | 7 | |
| 4 | 1 | |
| 5 | 15 | |
| 6 | Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with chemotherapeutic agents on patients' colon tumors grown in SCID mice. | 151 |
| 7 | 25 | |
| 8 | 32 | |
| 9 | Randomized comparison of two preoperative methods for preparation of the colon: oral administration of a solution of polyethylene glycol plus electrolytes and total parenteral nutrition. | 5 |
| 10 | 2 | |
| 11 | 41 | |
| 12 | 7 | |
| 13 | 10 | |
| 14 | 1 | |
| 15 | 54 | |
| 16 | [DNA index as a significant prognostic indicator of colorectal cancer]. | 2 |
| 17 | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.